Nucleic Acids Research, Vol 24, Issue 22 4558-4564, Copyright © 1996 by Oxford University Press
JP Vaughn, J Stekler, S Demirdji, JK Mills, MH Caruthers, JD Iglehart and JR Marks
Antisense activity against erbB-2 of a variety of sulfur-modified
oligonucleotides was examined in a breast cancer cell line which
overexpresses this oncogene. Using a 15 base anti-erbB-2 sequence
previously shown to be effective, various backbone configurations
containing phosphoromonothioate or phosphorodithioate linkages were
evaluated for antisense activity by a two-color flow cytometric assay. This
sequence was effective in inhibiting the production of erbB-2 protein when
it was configured as a monothioate at each linkage and as an alternating
dithioate/phosphodiester. Both of these compounds were also able to
specifically inhibit erbB-2 mRNA expression, indicative of RNase H-mediated
activity. The same sequence protected by either three dithioate or three
monothioate linkages at each end was ineffective as an antisense reagent,
suggesting that endonuclease activity is a significant determinant of the
stability of oligonucleotides. Finally, the erbB-2 sequence target was
shifted in an effort to improve antisense activity. A new lead sequence was
identified that was significantly more effective in inhibiting erbB-2
protein levels and retained activity at lower concentrations.
ARTICLES
Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Sheehan, B. Lunstad, C. M. Yamada, B. G. Stell, M. H. Caruthers, and D. J. Dellinger Biochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides Nucleic Acids Res., July 15, 2003; 31(14): 4109 - 4118. [Abstract] [Full Text] [PDF] |
||||
